Literature DB >> 19955022

An overview of international literature from cystic fibrosis registries 2. Neonatal screening and nutrition/growth.

Donatello Salvatore1, Roberto Buzzetti, Ermanno Baldo, Maria Pia Forneris, Vincenzina Lucidi, Daniela Manunza, Italo Marinelli, Barbara Messore, Anna Silvia Neri, Valeria Raia, Maria Lucia Furnari, Gianni Mastella.   

Abstract

BACKGROUND: This is the second article related to a review of the literature based on data from national cystic fibrosis (CF) registries up to June 2008 and covering a total of 115 studies. It focuses on two topics: neonatal screening (NS) and nutritional status, with particular reference to growth.
METHODS: Ten papers meeting the inclusion criteria were found on the topic of NS and its impact on the course of the disease, and were analyzed according to a dedicated grid. The issue of nutrition was addressed by 14 studies, analyzed according to similar criteria.
RESULTS: Most of the studies report benefits of early diagnosis by NS, albeit to variable degrees. The benefits were assessed in terms of better nutritional status and growth, but also in terms of lower overall morbidity rate as compared to subjects diagnosed by symptoms. The main biases of these studies, which partly undermine the validity of their results, are also analyzed. A part of our analysis on nutrition/growth is dedicated to the identification of the most suitable parameters to define malnutrition: in children older than two years the body mass index percentile (BMIp) appears to be the most sensitive and significantly associated with respiratory function. Better nutritional status and satisfactory growth appear to be associated with better lung function and lower risk of death. The relationship between nutritional status and socio-economic status is also of interest.
CONCLUSIONS: CF registry studies support the outcome of cohort observational studies i.e. that pre-symptomatic early diagnosis is beneficial, especially in terms of nutritional status and growth. Studies on nutrition indicate that good nutritional status is associated with better respiratory function and prognosis. Regarding methods, the need emerged to manage potential biases of this kind of non randomized studies, resorting to suitable statistical techniques, such as matching and stratification and, above all, to multivariate methods able to provide estimates adjusted for the main covariates tested. Copyright (c) 2009 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19955022     DOI: 10.1016/j.jcf.2009.11.002

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  7 in total

1.  The Pediatric Emergency Care Applied Research Network Registry: A Multicenter Electronic Health Record Registry of Pediatric Emergency Care.

Authors:  Sara J Deakyne Davies; Robert W Grundmeier; Diego A Campos; Katie L Hayes; Jamie Bell; Evaline A Alessandrini; Lalit Bajaj; James M Chamberlain; Marc H Gorelick; Rene Enriquez; T Charles Casper; Beth Scheid; Marlena Kittick; J Michael Dean; Elizabeth R Alpern
Journal:  Appl Clin Inform       Date:  2018-05-23       Impact factor: 2.342

Review 2.  New animal models of cystic fibrosis: what are they teaching us?

Authors:  Nicholas W Keiser; John F Engelhardt
Journal:  Curr Opin Pulm Med       Date:  2011-11       Impact factor: 3.155

Review 3.  Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher.

Authors:  Rhonda Szczesniak; Sonya L Heltshe; Sanja Stanojevic; Nicole Mayer-Hamblett
Journal:  J Cyst Fibros       Date:  2017-01-20       Impact factor: 5.482

4.  Effects of immediate telephone follow-up with providers on sweat chloride test timing after cystic fibrosis newborn screening identifies a single mutation.

Authors:  Alison La Pean; Michael H Farrell; Kerry L Eskra; Philip M Farrell
Journal:  J Pediatr       Date:  2012-10-24       Impact factor: 4.406

5.  A qualitative secondary evaluation of statewide follow-up interviews for abnormal newborn screening results for cystic fibrosis and sickle cell hemoglobinopathy.

Authors:  Alison La Pean; Jenelle L Collins; Stephanie A Christopher; Kerry L Eskra; Sara J Roedl; Audrey Tluczek; Michael H Farrell
Journal:  Genet Med       Date:  2012-02       Impact factor: 8.822

6.  A methodological framework for drug development in rare diseases.

Authors:  Patrice Nony; Polina Kurbatova; Agathe Bajard; Salma Malik; Charlotte Castellan; Sylvie Chabaud; Vitaly Volpert; Nathalie Eymard; Behrouz Kassai; Catherine Cornu
Journal:  Orphanet J Rare Dis       Date:  2014-11-18       Impact factor: 4.123

7.  Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: a UK CF registry-based study.

Authors:  Daniela K Schlüter; Kevin W Southern; Carol Dryden; Peter Diggle; David Taylor-Robinson
Journal:  Thorax       Date:  2019-11-26       Impact factor: 9.139

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.